Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?

Publisher： Karger

E-ISSN： 1423-0232|92|6|317-324

ISSN： 0030-2414

Source： Oncology, Vol.92, Iss.6, 2017-03, pp. : 317-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant systemic therapy for elderly women with breast cancer

By Henry N Lynn   Diehl Kathleen M   Hayes Daniel F  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 75-87

Future Medicine

Access to resources Recommend Favorite

Postoperative Hyperprolactinemia Could Predict Longer Disease-Free and Overall Survival in Node-Negative Breast Cancer Patients

By  

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 370-377

Karger

Access to resources Recommend Favorite

Clinical Relevance of Prognostic Factors in Axillary Node-Negative Breast Cancer

By  

Oncology Research and Treatment, Vol. 26, Iss. 5, 2003-11 ,pp. : 438-445

Karger

Access to resources Recommend Favorite

Will trastuzumab change the optimal adjuvant systemic therapy of patients with HER2-positive breast cancer?

By Santini Daniele   Vincenzi Bruno   Tonini Giuseppe  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

Elderly Breast Cancer Patients: Adjuvant Chemotherapy and Adjuvant Endocrine Therapy

By  

Gynäkologisch-geburtshilfliche Rundschau, Vol. 45, Iss. 3, 2005-06 ,pp. : 137-142

Karger

Access to resources Recommend Favorite